APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug Residue Testing Solution

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Drug Residue Testing Solution Market Analysis and Forecast 2026-2032

11 April 2026221 pages

Choose your research edition.

Industry ResearchDrug Residue Testing Solution Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Residue Testing Solution Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Drug Residue Testing Solution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Residue Testing Solution Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Drug Residue Testing Solution Market Analysis and Forecast 2026-2032221 pages · $4,950 USD

Market perspective

The global Drug Residue Testing Solution market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Drug Residue Testing Solution is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Drug Residue Testing Solution is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Drug Residue Testing Solution is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Drug Residue Testing Solution is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Drug Residue Testing Solution include FOSS, Bulteh 2000, Scope Electric, DSM, PerkinElmer, Charm Sciences, Chr. Hansen Holding, Bioeasy and Lactotronic, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Drug Residue Testing Solution, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Drug Residue Testing Solution, also provides the revenue of main regions and countries. Of the upcoming market potential for Drug Residue Testing Solution, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Drug Residue Testing Solution revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Drug Residue Testing Solution market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Drug Residue Testing Solution revenue, projected growth trends, production technology, application and end-user industry.

Drug Residue Testing Solution Segment by Company

FOSS

Bulteh 2000

Scope Electric

DSM

PerkinElmer

Charm Sciences

Chr. Hansen Holding

Bioeasy

Lactotronic

Specac

Florecers

Polymer Testing Lab

Cambrex

CTI

Drug Residue Testing Solution Segment by Type

Gas Chromatography

Liquid Chromatography

Others

Drug Residue Testing Solution Segment by Application

Food and Beverage

Vegetables and Fruits

Meat Products

Others

Drug Residue Testing Solution Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Residue Testing Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Residue Testing Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Residue Testing Solution.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Drug Residue Testing Solution in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Drug Residue Testing Solution company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Residue Testing Solution revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Drug Residue Testing Solution Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Gas Chromatography Major Player Table 3. Liquid Chromatography Major Player Table 4. Others Major Player Table 5. Global Drug Residue Testing Solution Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Food and Beverage Major Player Table 7. Vegetables and Fruits Major Player Table 8. Meat Products Major Player Table 9. Others Major Player Table 10. Drug Residue Testing Solution Industry Trends Table 11. Drug Residue Testing Solution Industry Drivers Table 12. Drug Residue Testing Solution Industry Opportunities and Challenges Table 13. Drug Residue Testing Solution Industry Restraints Table 14. Global Drug Residue Testing Solution Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Drug Residue Testing Solution Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Drug Residue Testing Solution Market Share by Region (2021-2026) Table 17. Global Drug Residue Testing Solution Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Drug Residue Testing Solution Market Share by Region (2027-2032) Table 19. Global Drug Residue Testing Solution Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Drug Residue Testing Solution Revenue Market Share by Players (2021-2026) Table 21. Global Drug Residue Testing Solution Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Drug Residue Testing Solution Key Players Headquarters & Area Served Table 23. Global Drug Residue Testing Solution Players, Product Type & Application Table 24. Global Drug Residue Testing Solution Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Drug Residue Testing Solution by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Drug Residue Testing Solution Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Drug Residue Testing Solution Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Drug Residue Testing Solution Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Drug Residue Testing Solution Revenue Market Share by Type (2021-2026) Table 31. Global Drug Residue Testing Solution Revenue Market Share by Type (2027-2032) Table 32. Global Drug Residue Testing Solution Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Drug Residue Testing Solution Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Drug Residue Testing Solution Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Drug Residue Testing Solution Revenue Market Share by Application (2021-2026) Table 36. Global Drug Residue Testing Solution Revenue Market Share by Application (2027-2032) Table 37. FOSS Company Information Table 38. FOSS Business Overview Table 39. FOSS Drug Residue Testing Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. FOSS Drug Residue Testing Solution Product Portfolio Table 41. FOSS Recent Development Table 42. Bulteh 2000 Company Information Table 43. Bulteh 2000 Business Overview Table 44. Bulteh 2000 Drug Residue Testing Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Bulteh 2000 Drug Residue Testing Solution Product Portfolio Table 46. Bulteh 2000 Recent Development Table 47. Scope Electric Company Information Table 48. Scope Electric Business Overview Table 49. Scope Electric Drug Residue Testing Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Scope Electric Drug Residue Testing Solution Product Portfolio Table 51. Scope Electric Recent Development Table 52. DSM Company Information Table 53. DSM Business Overview Table 54. DSM Drug Residue Testing Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. DSM Drug Residue Testing Solution Product Portfolio Table 56. DSM Recent Development Table 57. PerkinElmer Company Information Table 58. PerkinElmer Business Overview Table 59. PerkinElmer Drug Residue Testing Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. PerkinElmer Drug Residue Testing Solution Product Portfolio Table 61. PerkinElmer Recent Development Table 62. Charm Sciences Company Information Table 63. Charm Sciences Business Overview Table 64. Charm Sciences Drug Residue Testing Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Charm Sciences Drug Residue Testing Solution Product Portfolio Table 66. Charm Sciences Recent Development Table 67. Chr. Hansen Holding Company Information Table 68. Chr. Hansen Holding Business Overview Table 69. Chr. Hansen Holding Drug Residue Testing Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Chr. Hansen Holding Drug Residue Testing Solution Product Portfolio Table 71. Chr. Hansen Holding Recent Development Table 72. Bioeasy Company Information Table 73. Bioeasy Business Overview Table 74. Bioeasy Drug Residue Testing Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Bioeasy Drug Residue Testing Solution Product Portfolio Table 76. Bioeasy Recent Development Table 77. Lactotronic Company Information Table 78. Lactotronic Business Overview Table 79. Lactotronic Drug Residue Testing Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Lactotronic Drug Residue Testing Solution Product Portfolio Table 81. Lactotronic Recent Development Table 82. Specac Company Information Table 83. Specac Business Overview Table 84. Specac Drug Residue Testing Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Specac Drug Residue Testing Solution Product Portfolio Table 86. Specac Recent Development Table 87. Florecers Company Information Table 88. Florecers Business Overview Table 89. Florecers Drug Residue Testing Solution Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Florecers Drug Residue Testing Solution Product Portfolio Table 91. Florecers Recent Development Table 92. Polymer Testing Lab Company Information Table 93. Polymer Testing Lab Business Overview Table 94. Polymer Testing Lab Drug Residue Testing Solution Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Polymer Testing Lab Drug Residue Testing Solution Product Portfolio Table 96. Polymer Testing Lab Recent Development Table 97. Cambrex Company Information Table 98. Cambrex Business Overview Table 99. Cambrex Drug Residue Testing Solution Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Cambrex Drug Residue Testing Solution Product Portfolio Table 101. Cambrex Recent Development Table 102. CTI Company Information Table 103. CTI Business Overview Table 104. CTI Drug Residue Testing Solution Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. CTI Drug Residue Testing Solution Product Portfolio Table 106. CTI Recent Development Table 107. North America Drug Residue Testing Solution Revenue by Type (2021-2026) & (US$ Million) Table 108. North America Drug Residue Testing Solution Revenue by Type (2027-2032) & (US$ Million) Table 109. North America Drug Residue Testing Solution Revenue by Application (2021-2026) & (US$ Million) Table 110. North America Drug Residue Testing Solution Revenue by Application (2027-2032) & (US$ Million) Table 111. North America Drug Residue Testing Solution Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. North America Drug Residue Testing Solution Revenue by Country (2021-2026) & (US$ Million) Table 113. North America Drug Residue Testing Solution Revenue by Country (US$ Million) & (2027-2032) Table 114. Europe Drug Residue Testing Solution Revenue by Type (2021-2026) & (US$ Million) Table 115. Europe Drug Residue Testing Solution Revenue by Type (2027-2032) & (US$ Million) Table 116. Europe Drug Residue Testing Solution Revenue by Application (2021-2026) & (US$ Million) Table 117. Europe Drug Residue Testing Solution Revenue by Application (2027-2032) & (US$ Million) Table 118. Europe Drug Residue Testing Solution Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Europe Drug Residue Testing Solution Revenue by Country (2021-2026) & (US$ Million) Table 120. Europe Drug Residue Testing Solution Revenue by Country (US$ Million) & (2027-2032) Table 121. China Drug Residue Testing Solution Revenue by Type (2021-2026) & (US$ Million) Table 122. China Drug Residue Testing Solution Revenue by Type (2027-2032) & (US$ Million) Table 123. China Drug Residue Testing Solution Revenue by Application (2021-2026) & (US$ Million) Table 124. China Drug Residue Testing Solution Revenue by Application (2027-2032) & (US$ Million) Table 125. Asia Drug Residue Testing Solution Revenue by Type (2021-2026) & (US$ Million) Table 126. Asia Drug Residue Testing Solution Revenue by Type (2027-2032) & (US$ Million) Table 127. Asia Drug Residue Testing Solution Revenue by Application (2021-2026) & (US$ Million) Table 128. Asia Drug Residue Testing Solution Revenue by Application (2027-2032) & (US$ Million) Table 129. Asia Drug Residue Testing Solution Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 130. Asia Drug Residue Testing Solution Revenue by Region (US$ Million) & (2021-2026) Table 131. Asia Drug Residue Testing Solution Revenue by Region (US$ Million) & (2027-2032) Table 132. SAMEA Drug Residue Testing Solution Revenue by Type (2021-2026) & (US$ Million) Table 133. SAMEA Drug Residue Testing Solution Revenue by Type (2027-2032) & (US$ Million) Table 134. SAMEA Drug Residue Testing Solution Revenue by Application (2021-2026) & (US$ Million) Table 135. SAMEA Drug Residue Testing Solution Revenue by Application (2027-2032) & (US$ Million) Table 136. SAMEA Drug Residue Testing Solution Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. SAMEA Drug Residue Testing Solution Revenue by Country (2021-2026) & (US$ Million) Table 138. SAMEA Drug Residue Testing Solution Revenue by Country (US$ Million) & (2027-2032) Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Drug Residue Testing Solution Image Figure 2. Global Drug Residue Testing Solution Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drug Residue Testing Solution Market Size Share 2021 VS 2025 VS 2032 Figure 4. Gas Chromatography Image Figure 5. Liquid Chromatography Image Figure 6. Others Image Figure 7. Global Drug Residue Testing Solution Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Drug Residue Testing Solution Market Size Share 2021 VS 2025 VS 2032 Figure 9. Food and Beverage Image Figure 10. Vegetables and Fruits Image Figure 11. Meat Products Image Figure 12. Others Image Figure 13. Global Drug Residue Testing Solution Market Size (US$ Million) & (2021-2032) Figure 14. Global Drug Residue Testing Solution Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Drug Residue Testing Solution Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Drug Residue Testing Solution Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Drug Residue Testing Solution Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Drug Residue Testing Solution Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Drug Residue Testing Solution Revenue Market Share by Type (2021-2032) Figure 21. Global Drug Residue Testing Solution Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Drug Residue Testing Solution Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Drug Residue Testing Solution Revenue Market Share by Application (2021-2032) Figure 24. North America Drug Residue Testing Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Drug Residue Testing Solution Revenue Share by Type (2021-2032) Figure 26. North America Drug Residue Testing Solution Revenue Share by Application (2021-2032) Figure 27. North America Drug Residue Testing Solution Revenue Share by Country (2021-2032) Figure 28. United States Drug Residue Testing Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Drug Residue Testing Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Drug Residue Testing Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Drug Residue Testing Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Drug Residue Testing Solution Revenue Share by Type (2021-2032) Figure 33. Europe Drug Residue Testing Solution Revenue Share by Application (2021-2032) Figure 34. Europe Drug Residue Testing Solution Revenue Share by Country (2021-2032) Figure 35. Germany Drug Residue Testing Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Drug Residue Testing Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Drug Residue Testing Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Drug Residue Testing Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Drug Residue Testing Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Drug Residue Testing Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Drug Residue Testing Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Drug Residue Testing Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Drug Residue Testing Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Drug Residue Testing Solution Revenue Share by Type (2021-2032) Figure 45. China Drug Residue Testing Solution Revenue Share by Application (2021-2032) Figure 46. Asia Drug Residue Testing Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Drug Residue Testing Solution Revenue Share by Type (2021-2032) Figure 48. Asia Drug Residue Testing Solution Revenue Share by Application (2021-2032) Figure 49. Asia Drug Residue Testing Solution Revenue Share by Region (2021-2032) Figure 50. Japan Drug Residue Testing Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Drug Residue Testing Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Drug Residue Testing Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Drug Residue Testing Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Drug Residue Testing Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Drug Residue Testing Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Drug Residue Testing Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Drug Residue Testing Solution Revenue Share by Type (2021-2032) Figure 58. SAMEA Drug Residue Testing Solution Revenue Share by Application (2021-2032) Figure 59. SAMEA Drug Residue Testing Solution Revenue Share by Country (2021-2032) Figure 60. Brazil Drug Residue Testing Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Drug Residue Testing Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Drug Residue Testing Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Drug Residue Testing Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Drug Residue Testing Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Drug Residue Testing Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Drug Residue Testing Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Drug Residue Testing Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Drug Residue Testing Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Drug Residue Testing Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Drug Residue Testing Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Gas Chromatography
  • Liquid Chromatography
  • Others
Applications
  • Food and Beverage
  • Vegetables and Fruits
  • Meat Products
  • Others
Companies covered
  • FOSS
  • Bulteh 2000
  • Scope Electric
  • DSM
  • PerkinElmer
  • Charm Sciences
  • Chr. Hansen Holding
  • Bioeasy
  • Lactotronic
  • Specac
  • Florecers
  • Polymer Testing Lab
  • Cambrex
  • CTI

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Drug Residue Testing Solution Market by Type
  3. 1.2.1 Global Drug Residue Testing Solution Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Gas Chromatography
  5. 1.2.3 Liquid Chromatography
  6. 1.2.4 Others
  7. 1.3 Drug Residue Testing Solution Market by Application
  8. 1.3.1 Global Drug Residue Testing Solution Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Food and Beverage
  10. 1.3.3 Vegetables and Fruits
  11. 1.3.4 Meat Products
  12. 1.3.5 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Drug Residue Testing Solution Market Dynamics
  1. 2.1 Drug Residue Testing Solution Industry Trends
  2. 2.2 Drug Residue Testing Solution Industry Drivers
  3. 2.3 Drug Residue Testing Solution Industry Opportunities and Challenges
  4. 2.4 Drug Residue Testing Solution Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Drug Residue Testing Solution Market Perspective (2021-2032)
  2. 3.2 Global Drug Residue Testing Solution Growth Trends by Region
  3. 3.2.1 Global Drug Residue Testing Solution Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Drug Residue Testing Solution Market Size by Region (2021-2026)
  5. 3.2.3 Global Drug Residue Testing Solution Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Drug Residue Testing Solution Revenue by Players
  2. 4.1.1 Global Drug Residue Testing Solution Revenue by Players (2021-2026)
  3. 4.1.2 Global Drug Residue Testing Solution Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Drug Residue Testing Solution Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Drug Residue Testing Solution Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Drug Residue Testing Solution Key Players Headquarters & Area Served
  7. 4.4 Global Drug Residue Testing Solution Players, Product Type & Application
  8. 4.5 Global Drug Residue Testing Solution Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Drug Residue Testing Solution Market CR5 and HHI
  11. 4.6.3 2025 Drug Residue Testing Solution Tier 1, Tier 2, and Tier 3
5 Drug Residue Testing Solution Market Size by Type
  1. 5.1 Global Drug Residue Testing Solution Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Drug Residue Testing Solution Revenue by Type (2021-2032)
  3. 5.3 Global Drug Residue Testing Solution Revenue Market Share by Type (2021-2032)
6 Drug Residue Testing Solution Market Size by Application
  1. 6.1 Global Drug Residue Testing Solution Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Drug Residue Testing Solution Revenue by Application (2021-2032)
  3. 6.3 Global Drug Residue Testing Solution Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 FOSS
  2. 7.1.1 FOSS Company Information
  3. 7.1.2 FOSS Business Overview
  4. 7.1.3 FOSS Drug Residue Testing Solution Revenue and Gross Margin (2021-2026)
  5. 7.1.4 FOSS Drug Residue Testing Solution Product Portfolio
  6. 7.1.5 FOSS Recent Developments
  7. 7.2 Bulteh 2000
  8. 7.2.1 Bulteh 2000 Company Information
  9. 7.2.2 Bulteh 2000 Business Overview
  10. 7.2.3 Bulteh 2000 Drug Residue Testing Solution Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Bulteh 2000 Drug Residue Testing Solution Product Portfolio
  12. 7.2.5 Bulteh 2000 Recent Developments
  13. 7.3 Scope Electric
  14. 7.3.1 Scope Electric Company Information
  15. 7.3.2 Scope Electric Business Overview
  16. 7.3.3 Scope Electric Drug Residue Testing Solution Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Scope Electric Drug Residue Testing Solution Product Portfolio
  18. 7.3.5 Scope Electric Recent Developments
  19. 7.4 DSM
  20. 7.4.1 DSM Company Information
  21. 7.4.2 DSM Business Overview
  22. 7.4.3 DSM Drug Residue Testing Solution Revenue and Gross Margin (2021-2026)
  23. 7.4.4 DSM Drug Residue Testing Solution Product Portfolio
  24. 7.4.5 DSM Recent Developments
  25. 7.5 PerkinElmer
  26. 7.5.1 PerkinElmer Company Information
  27. 7.5.2 PerkinElmer Business Overview
  28. 7.5.3 PerkinElmer Drug Residue Testing Solution Revenue and Gross Margin (2021-2026)
  29. 7.5.4 PerkinElmer Drug Residue Testing Solution Product Portfolio
  30. 7.5.5 PerkinElmer Recent Developments
  31. 7.6 Charm Sciences
  32. 7.6.1 Charm Sciences Company Information
  33. 7.6.2 Charm Sciences Business Overview
  34. 7.6.3 Charm Sciences Drug Residue Testing Solution Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Charm Sciences Drug Residue Testing Solution Product Portfolio
  36. 7.6.5 Charm Sciences Recent Developments
  37. 7.7 Chr. Hansen Holding
  38. 7.7.1 Chr. Hansen Holding Company Information
  39. 7.7.2 Chr. Hansen Holding Business Overview
  40. 7.7.3 Chr. Hansen Holding Drug Residue Testing Solution Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Chr. Hansen Holding Drug Residue Testing Solution Product Portfolio
  42. 7.7.5 Chr. Hansen Holding Recent Developments
  43. 7.8 Bioeasy
  44. 7.8.1 Bioeasy Company Information
  45. 7.8.2 Bioeasy Business Overview
  46. 7.8.3 Bioeasy Drug Residue Testing Solution Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Bioeasy Drug Residue Testing Solution Product Portfolio
  48. 7.8.5 Bioeasy Recent Developments
  49. 7.9 Lactotronic
  50. 7.9.1 Lactotronic Company Information
  51. 7.9.2 Lactotronic Business Overview
  52. 7.9.3 Lactotronic Drug Residue Testing Solution Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Lactotronic Drug Residue Testing Solution Product Portfolio
  54. 7.9.5 Lactotronic Recent Developments
  55. 7.10 Specac
  56. 7.10.1 Specac Company Information
  57. 7.10.2 Specac Business Overview
  58. 7.10.3 Specac Drug Residue Testing Solution Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Specac Drug Residue Testing Solution Product Portfolio
  60. 7.10.5 Specac Recent Developments
  61. 7.11 Florecers
  62. 7.11.1 Florecers Company Information
  63. 7.11.2 Florecers Business Overview
  64. 7.11.3 Florecers Drug Residue Testing Solution Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Florecers Drug Residue Testing Solution Product Portfolio
  66. 7.11.5 Florecers Recent Developments
  67. 7.12 Polymer Testing Lab
  68. 7.12.1 Polymer Testing Lab Company Information
  69. 7.12.2 Polymer Testing Lab Business Overview
  70. 7.12.3 Polymer Testing Lab Drug Residue Testing Solution Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Polymer Testing Lab Drug Residue Testing Solution Product Portfolio
  72. 7.12.5 Polymer Testing Lab Recent Developments
  73. 7.13 Cambrex
  74. 7.13.1 Cambrex Company Information
  75. 7.13.2 Cambrex Business Overview
  76. 7.13.3 Cambrex Drug Residue Testing Solution Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Cambrex Drug Residue Testing Solution Product Portfolio
  78. 7.13.5 Cambrex Recent Developments
  79. 7.14 CTI
  80. 7.14.1 CTI Company Information
  81. 7.14.2 CTI Business Overview
  82. 7.14.3 CTI Drug Residue Testing Solution Revenue and Gross Margin (2021-2026)
  83. 7.14.4 CTI Drug Residue Testing Solution Product Portfolio
  84. 7.14.5 CTI Recent Developments
8 North America
  1. 8.1 North America Drug Residue Testing Solution Revenue (2021-2032)
  2. 8.2 North America Drug Residue Testing Solution Revenue by Type (2021-2032)
  3. 8.2.1 North America Drug Residue Testing Solution Revenue by Type (2021-2026)
  4. 8.2.2 North America Drug Residue Testing Solution Revenue by Type (2027-2032)
  5. 8.3 North America Drug Residue Testing Solution Revenue Share by Type (2021-2032)
  6. 8.4 North America Drug Residue Testing Solution Revenue by Application (2021-2032)
  7. 8.4.1 North America Drug Residue Testing Solution Revenue by Application (2021-2026)
  8. 8.4.2 North America Drug Residue Testing Solution Revenue by Application (2027-2032)
  9. 8.5 North America Drug Residue Testing Solution Revenue Share by Application (2021-2032)
  10. 8.6 North America Drug Residue Testing Solution Revenue by Country
  11. 8.6.1 North America Drug Residue Testing Solution Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Drug Residue Testing Solution Revenue by Country (2021-2026)
  13. 8.6.3 North America Drug Residue Testing Solution Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Drug Residue Testing Solution Revenue (2021-2032)
  2. 9.2 Europe Drug Residue Testing Solution Revenue by Type (2021-2032)
  3. 9.2.1 Europe Drug Residue Testing Solution Revenue by Type (2021-2026)
  4. 9.2.2 Europe Drug Residue Testing Solution Revenue by Type (2027-2032)
  5. 9.3 Europe Drug Residue Testing Solution Revenue Share by Type (2021-2032)
  6. 9.4 Europe Drug Residue Testing Solution Revenue by Application (2021-2032)
  7. 9.4.1 Europe Drug Residue Testing Solution Revenue by Application (2021-2026)
  8. 9.4.2 Europe Drug Residue Testing Solution Revenue by Application (2027-2032)
  9. 9.5 Europe Drug Residue Testing Solution Revenue Share by Application (2021-2032)
  10. 9.6 Europe Drug Residue Testing Solution Revenue by Country
  11. 9.6.1 Europe Drug Residue Testing Solution Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Drug Residue Testing Solution Revenue by Country (2021-2026)
  13. 9.6.3 Europe Drug Residue Testing Solution Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Drug Residue Testing Solution Revenue (2021-2032)
  2. 10.2 China Drug Residue Testing Solution Revenue by Type (2021-2032)
  3. 10.2.1 China Drug Residue Testing Solution Revenue by Type (2021-2026)
  4. 10.2.2 China Drug Residue Testing Solution Revenue by Type (2027-2032)
  5. 10.3 China Drug Residue Testing Solution Revenue Share by Type (2021-2032)
  6. 10.4 China Drug Residue Testing Solution Revenue by Application (2021-2032)
  7. 10.4.1 China Drug Residue Testing Solution Revenue by Application (2021-2026)
  8. 10.4.2 China Drug Residue Testing Solution Revenue by Application (2027-2032)
  9. 10.5 China Drug Residue Testing Solution Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Drug Residue Testing Solution Revenue (2021-2032)
  2. 11.2 Asia Drug Residue Testing Solution Revenue by Type (2021-2032)
  3. 11.2.1 Asia Drug Residue Testing Solution Revenue by Type (2021-2026)
  4. 11.2.2 Asia Drug Residue Testing Solution Revenue by Type (2027-2032)
  5. 11.3 Asia Drug Residue Testing Solution Revenue Share by Type (2021-2032)
  6. 11.4 Asia Drug Residue Testing Solution Revenue by Application (2021-2032)
  7. 11.4.1 Asia Drug Residue Testing Solution Revenue by Application (2021-2026)
  8. 11.4.2 Asia Drug Residue Testing Solution Revenue by Application (2027-2032)
  9. 11.5 Asia Drug Residue Testing Solution Revenue Share by Application (2021-2032)
  10. 11.6 Asia Drug Residue Testing Solution Revenue by Country
  11. 11.6.1 Asia Drug Residue Testing Solution Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Drug Residue Testing Solution Revenue by Country (2021-2026)
  13. 11.6.3 Asia Drug Residue Testing Solution Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Drug Residue Testing Solution Revenue (2021-2032)
  2. 12.2 SAMEA Drug Residue Testing Solution Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Drug Residue Testing Solution Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Drug Residue Testing Solution Revenue by Type (2027-2032)
  5. 12.3 SAMEA Drug Residue Testing Solution Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Drug Residue Testing Solution Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Drug Residue Testing Solution Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Drug Residue Testing Solution Revenue by Application (2027-2032)
  9. 12.5 SAMEA Drug Residue Testing Solution Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Drug Residue Testing Solution Revenue by Country
  11. 12.6.1 SAMEA Drug Residue Testing Solution Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Drug Residue Testing Solution Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Drug Residue Testing Solution Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst